BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
128 results:

  • 1. Performance of an automated total body mapping algorithm to detect melanocytic lesions of clinical relevance.
    Winkler JK; Kommoss KS; Toberer F; Enk A; Maul LV; Navarini AA; Hudson J; Salerni G; Rosenberger A; Haenssle HA
    Eur J Cancer; 2024 May; 202():114026. PubMed ID: 38547776
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Examining the causal association between psoriasis and bladder cancer: A two-sample Mendelian randomization analysis.
    Du L; Wang B; Wen J; Zhang N
    Skin Res Technol; 2024 Apr; 30(4):e13663. PubMed ID: 38533746
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic causal relationship between gut microbiota and cutaneous melanoma: a two-sample Mendelian randomization study.
    Wang P; Liu T; Zhang Q; Luo P
    Melanoma Res; 2024 Jun; 34(3):225-233. PubMed ID: 38469881
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. NnU-Net versus mesh growing algorithm as a tool for the robust and timely segmentation of neurosurgical 3D images in contrast-enhanced T1 MRI scans.
    de Boer M; Kos TM; Fick T; van Doormaal JAM; Colombo E; Kuijf HJ; Robe PAJT; Regli LP; Bartels LW; van Doormaal TPC
    Acta Neurochir (Wien); 2024 Feb; 166(1):92. PubMed ID: 38376564
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The effect of microRNA-9 overexpression on inhibition of melanoma cancer stem cells tumorigenicity.
    Parisa S; Amirhossein I; Hamed YS; Javad F; Masoumeh A; Pardis K; Mahshad D; Faezeh K; Marzieh E
    Melanoma Res; 2024 Apr; 34(2):105-117. PubMed ID: 38224358
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness.
    Monti M; Benerini Gatta L; Bugatti M; Pezzali I; Picinoli S; Manfredi M; Lavazza A; Vanella VV; De Giorgis V; Zanatta L; Missale F; Lonardi S; Zanetti B; Bozzoni G; Cadei M; Abate A; Vergani B; Balzarini P; Battocchio S; Facco C; Turri-Zanoni M; Castelnuovo P; Nicolai P; Fonsatti E; Leone BE; Marengo E; Sigala S; Ronca R; Perego M; Lombardi D; Vermi W
    J Transl Med; 2024 Jan; 22(1):35. PubMed ID: 38191367
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
    Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
    Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Thyroid dysfunction and risk of cutaneous malignant melanoma: a bidirectional two-sample Mendelian randomization study.
    Dong H; Pan L; Shen Y; Xu Q; Hu J; Hu Z; Fei Y
    Front Endocrinol (Lausanne); 2023; 14():1239883. PubMed ID: 38093968
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Racial and ethnic minorities in lower income brackets are associated with late-stage diagnosis of non-ocular melanoma.
    Joshi P; Ogobuiro I; Hernandez A; De La Cruz Ku G; Noe DG; Feun L; Liu ZJ; Möller MG
    Cancer Epidemiol; 2023 Dec; 87():102489. PubMed ID: 37979223
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. skin cancers in Medicare Beneficiaries With Actinic Keratoses.
    Mohr C; Li Y; Navsaria LJ; Hinkston CL; Shete SS; Margolis DJ; Wehner MR
    JAMA Dermatol; 2023 Dec; 159(12):1368-1372. PubMed ID: 37938822
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diagnostic value of high-frequency ultrasound (HFUS) in evaluation of subcutaneous lesions.
    Miao Y; Ren WW; Yang FY; Li L; Wu L; Dan Shan D; Chen ZT; Wang LF; Wang Q; Guo LH
    Skin Res Technol; 2023 Sep; 29(9):e13464. PubMed ID: 37753674
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ranitidine Use and Incident cancer in a Multinational Cohort.
    You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
    JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    Romano B; Maresca DC; Somma F; Ahmadi P; Putra MY; Rahmawati SI; Chianese G; Formisano C; Ianaro A; Ercolano G
    Mar Drugs; 2023 Jun; 21(7):. PubMed ID: 37504902
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.
    Yonekura S; Endo Y; Fujii H; Ishikawa M; Egawa G; Kabashima K
    J Dermatol; 2023 Nov; 50(11):1493-1496. PubMed ID: 37400887
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of Genes Associated With Epithelial-Mesenchymal Transition in Merkel Cell Polyomavirus-Negative Merkel Cell Carcinoma.
    Karpinski P; Rosales I; Laczmanski L; Kowalik A; Wenson S; Hoang MP
    Lab Invest; 2023 Aug; 103(8):100177. PubMed ID: 37207705
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Anatomic Locations of Procedurally Treated Keratinocyte Carcinomas in the US Medicare Population.
    Navsaria LJ; Li Y; Tripathy S; Cox ML; Hinkston CL; Margolis DJ; Wehner MR
    JAMA Dermatol; 2023 Jun; 159(6):643-647. PubMed ID: 37074701
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Decoding molecular programs in melanoma brain metastases.
    Radke J; Schumann E; Onken J; Koll R; Acker G; Bodnar B; Senger C; Tierling S; Möbs M; Vajkoczy P; Vidal A; Högler S; Kodajova P; Westphal D; Meier F; Heppner F; Kreuzer-Redmer S; Grebien F; Jürchott K; Redmer T
    Nat Commun; 2022 Nov; 13(1):7304. PubMed ID: 36435874
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exosomal miR-22-3p from Mesenchymal Stem Cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma Cells by Regulating
    Chen Y; Fang Y; Li L; Luo H; Cao T; Tu B
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):275. PubMed ID: 36224027
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nuclear focal adhesion kinase induces APC/C activator protein cdh1-mediated cyclin-dependent kinase 4/6 degradation and inhibits melanoma proliferation.
    Murphy JM; Jeong K; Ahn EE; Lim SS
    J Biol Chem; 2022 Jun; 298(6):102013. PubMed ID: 35525274
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.
    Baqai U; Purwin TJ; Bechtel N; Chua V; Han A; Hartsough EJ; Kuznetsoff JN; Harbour JW; Aplin AE
    Mol Cancer Res; 2022 Aug; 20(8):1260-1271. PubMed ID: 35426938
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.